Research article · 28 Feb 2023
Research articlePublished 31 May 2016
Atherosclerosis and the Menopause
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Atherosclerosis is the process whereby atheromatous plaques develop in large and medium-sized arteries. In premenopausal women plaque formation is a very rare event in the absence of high risk factors. In the perimenopausal period simple atheromatous plaques formation occurs in the early stages. With the ageing process and years from menopause, late-stage complicated plaques result. The menopause is characterized by a steep rise in the atherogenous lipid profile. Following the climacteric, blood pressure rises increasing the occurrence of hypertension. Pro-atherogenic circulating haemostatic factors such as fibrinogen, plasmogen activator-1, factor VII, homocysteine and von Willebrand factor all increase after the menopause. As evidenceof a chronic inflammatory process following the menopause hs-C reactive protein increases after the menopause. The pathogenesis of atherosclerosis appears to initiate from an inflammatory reaction following injury to the endothelium due to shear forces on the vessel wall. Through the presence of adhesion molecules, monocytes are recruited into the endothelium and later differentiate into macrophages. In the presence of chronic inflammation more lipid is deposited followed by smooth muscle proliferation in the vessel wall. Collagen and proteoglycans are produced at the site of the atherosclerotic plaque as part of the ongoing chronic inflammatory process. With further accumulation of connective tissue, calcium deposition ensues resulting in end-stage atheromatous plaque formation. Complicated plaque formation is irreversible and does not appear to be amenable to treatment with lipid reducing agents such as the lipostatins and oestrogens. Conversely early simple plaques formation may be modulated by lipid-reducing drugs and this has also been demonstrated with hormone replacement therapy given during the climacteric or early after the menopause. Hormone replacement therapy appears to favourably modulate the surrogates for atherosclerosis possibly attenuating cardiovascular disease in postmenopausal women.. .
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
Prevalence of menopausal hormone therapy and alternative methods; health benefits experienced by peri- and postmenopausal polish women
Research article · 23 Oct 2017
Correlation of Pericoronary Epicardial Adipose Tissue with Coronary Artery Calcification, and Coronary Atherosclerosis in Egyptian Post-Menopausal Women
Conference abstract · 24 Aug 2022
Investigating the association between metabolic syndrome and menopause age, number of births, and sexual performance in postmenopausal women at 5 health centers in Tehran
Review article · 29 May 2021
The Postmenopausal/menopause, bone mineral density and whole body vibration: a short review
More from this journal
The newest in Andrology & Gynecology: Current Research.
Research article · 30 Jun 2026
NOA-SERA: Combined Autologous Progenitor Cells and Platelet-Derived Growth Factors for Male Factor Infertility Due to Non-Obstructive Azoospermia (NOA) and Severe Oligoasthenoteratozoospermia (OATS)-A Case Series
Editorial · 28 Mar 2025
Advances in Male Infertility Diagnosis and Treatment: A Contemporary Overview
Editorial · 28 Mar 2025
Advances in Urogenital Surgery: Minimally Invasive Techniques in Andrology and Gynecology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAndrology & Gynecology: Current Research
- SubjectNephrology & Urology
- SubjectReproductive Medicine & Gynaecology
- BylineArticles whose byline prints “Yves Muscat Baron”

